Adenosine uptake-dependent C6 cell growth inhibition

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Adenine nucleotides and adenosine play crucial roles in cellular processes.
• Understanding their impact on glioma cell proliferation is vital for potential therapeutic strategies.

Purpose of the Study:

• To elucidate the mechanisms by which adenine nucleotides and adenosine affect C6 glioma cell proliferation.
• To investigate the role of nucleoside transporters and intracellular metabolism in these effects.

Main Methods:

• Cell proliferation assays using C6 glioma cells.
• Enzyme inhibition studies targeting ecto-5'-nucleotidase and adenosine deaminase.
• Assessment of nucleoside transporter (ENT-1, ENT-2) expression and function.
• Pharmacological inhibition of adenosine kinase and analysis of uridine's effect.

Main Results:

• Adenine nucleotides, particularly AMP, and adenosine inhibited C6 cell growth in a dose- and time-dependent manner.
• Ecto-5'-nucleotidase inhibition reversed AMP-induced growth inhibition, while adenosine deaminase affected both AMP and adenosine.
• Equilibrative nucleoside transporter (ENT) inhibitors and an adenosine kinase inhibitor attenuated the growth inhibition.
• Reversal of growth inhibition by uridine suggested intracellular pyrimidine starvation as a key mechanism.

Conclusions:

• Extracellular adenine nucleotides inhibit C6 cell growth by converting to adenosine, which is then transported into cells.
• Intracellular adenosine kinase activity and subsequent AMP accumulation lead to pyrimidine starvation, causing cytostasis.
• This pathway highlights a potential therapeutic target for glioma treatment.